Overexpression of RGC-32 in colon cancer and other tumors
Tài liệu tham khảo
Badea, 2002, RGC-32 increases p34CDC2 kinase activity and entry of aortic smooth muscle cells into S-phase, J. Biol. Chem., 277, 502, 10.1074/jbc.M109354200
Gerdes, 1984, Cell cycle analysis of a cell proliferation-associated human nuclear antigen defined by the monoclonal antibody Ki-67, J. Immunol., 133, 1710, 10.4049/jimmunol.133.4.1710
Handa, 1999, Expression of cell cycle markers in colorectal carcinoma: superiority of cyclin A as an indicator of poor prognosis, Int. J. Cancer, 84, 225, 10.1002/(SICI)1097-0215(19990621)84:3<225::AID-IJC5>3.0.CO;2-A
Kallakury, 1997, The prognostic significance of p34cdc2 and cyclin D1 protein expression in prostate adenocarcinoma, Cancer, 80, 753, 10.1002/(SICI)1097-0142(19970815)80:4<753::AID-CNCR15>3.0.CO;2-S
Kim, 1999, Amplified CDK2 and cdc2 activities in primary colorectal carcinoma, Cancer, 85, 546, 10.1002/(SICI)1097-0142(19990201)85:3<546::AID-CNCR5>3.0.CO;2-0
Niculescu, 1997, Activation of Ras and mitogen-activated protein kinase pathway by terminal complement complexes is G protein dependent, J. Immunol., 158, 4405, 10.4049/jimmunol.158.9.4405
Nigg, 2001, Mitotic kinases as regulators of cell division and its checkpoints, Nat. Rev., Mol. Cell Biol., 2, 21, 10.1038/35048096
Rus, 1996, Sublytic complement attack induces cell cycle in oligodendrocytes, J. Immunol., 156, 4892, 10.4049/jimmunol.156.12.4892
Suzuki, 1992, Ki-67 antibody labeling index in colorectal carcinoma, J. Clin. Gastroenterol., 15, 317, 10.1097/00004836-199212000-00010
Vermeulen, 2003, The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer, Cell Prolif., 36, 131, 10.1046/j.1365-2184.2003.00266.x